Overview and application of phenolsulfonethylamine

Etamsylate is a hemostatic drug mainly used to prevent and treat bleeding caused by increased capillary permeability, such as bleeding before and after surgery, menorrhagia, etc. Its mechanism of action is to enhance platelet adhesion and shrink capillaries. This article will start from the pharmacological effects, clinical applications, manufacturers and precautions, focusing on analyzing its hemostatic effect and principles of rational drug use.

Pharmacological effects and indications

Ethylamine achieves hemostatic effect by promoting platelet production and enhancing its function while reducing capillary permeability. Clinically applicable to a variety of bleeding disorders, such asGastrointestinal bleeding, gum bleedingand postpartum hemorrhage, etc. Research shows that its combination with vitamin K can improve the efficacy ("Chinese Pharmacopoeia", 2020 edition). It should be noted that this drug is not suitable for serious conditions such as bleeding from large arteries.

Clinical Application and Combination Medication

In surgery, fenethylamine is often used as an auxiliary drug to reduce intraoperative bleeding, especially forGeneral Surgery and Obstetrics and Gynecology Surgery. For example, data from a tertiary hospital shows that preoperative use can reduce intraoperative bleeding by 20% (data source: "Journal of Clinical Surgery" 2021). When used in combination with tranexamic acid, coagulation function needs to be monitored to avoid the risk of thrombosis.

Manufacturer and dosage form

Notes and Summary

When using fenethylamine, you must strictly follow the doctor's advice to avoid the risk of thrombosis caused by long-term use of large doses. Pregnant and lactating women should take medication after evaluation by a doctor. As a classic hemostatic drug, it is cost-effective and safe, but the dosage form and course of treatment need to be selected based on the patient's individual conditions. Rational use of medications can maximize their clinical value.

Citing sources

1. "Chinese Pharmacopoeia" 2020 Edition (National Pharmacopoeia Commission)
2. "Journal of Clinical Surgery" 2021 Issue 12
3. Official websites of manufacturers: Shandong Xinhua Pharmaceutical, Shanghai Xinyi Pharmaceutical, Guangzhou Baiyunshan Pharmaceutical